Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases

Parkinsonism and Related Disorders

Volumn 15, Issue 7, 2009, Pages 516-520

  Goldstein, David S ^a   Sewell, LaToya ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Biomarker; Fluorodopa; Fluorodopamine; Multiple system atrophy; Olfaction; Parkinson; PET

Indexed keywords

6 FLUORODOPAMINE F 18;

ADULT; AGED; ANOSMIA; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NORADRENERGIC SYSTEM; OCCIPITAL CORTEX; PARKINSONISM; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RADIOACTIVITY; SCORING SYSTEM; SHY DRAGER SYNDROME; SMELLING DISORDER; SUBSTANTIA NIGRA;

AGED; BRAIN; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; OLFACTION DISORDERS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PURE AUTONOMIC FAILURE; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX;

EID: 67650736208     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.12.009     Document Type: Article

References (30)

1. Durrieu G., Senard J.M., Rascol O., Tran M.A., Lataste X., Rascol A., et al. Blood pressure and plasma catecholamines in never-treated Parkinsonian patients: effect of a selective D1 agonist (CY 208-243). Neurology 40 (1990) 707-709
2. Brooks D.J., Salmon E.P., Mathias C.J., Quinn N., Leenders K.L., Bannister R., et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 113 (1990) 1539-1552
3. Hoshi H., Kuwabara H., Leger G., Cumming P., Guttman M., and Gjedde A. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. J Cereb Blood Flow Metab 13 (1993) 57-69
4. Hague K., Lento P., Morgello S., Caro S., and Kaufmann H. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (Berl) 94 (1997) 192-196
5. Wakabayashi K., and Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 38 Suppl 2 (1997) 2-7
6. Sharabi Y., Imrich R., Holmes C., Pechnik S., and Goldstein D.S. Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson disease with orthostatic hypotension. Movement Dis 23 (2008) 1725-1732
7. Kaufmann H., Nahm K., Purohit D., and Wolfe D. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63 (2004) 1093-1095
8. Goldstein D.S., Holmes C., Sato T., Bernson M., Mizrahi N., Imrich R., et al. Central dopamine deficiency in pure autonomic failure. Clin Auton Res 18 (2008) 166-171
9. Doty R.L., Riklan M., Deems D.A., Reynolds C., and Stellar S. The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 25 (1989) 166-171
10. Braak H., Ghebremedhin E., Rub U., Bratzke H., and Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318 (2004) 121-134
11. Lee P.H., Yeo S.H., Kim H.J., and Youm H.Y. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 21 (2006) 1975-1977
12. Orimo S., Oka T., Miura H., Tsuchiya K., Mori F., Wakabayashi K., et al. Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 73 (2002) 776-777
13. Goldstein D.S., Holmes C., Li S.T., Bruce S., Metman L.V., and Cannon R.O. 3rd. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133 (2000) 338-347
14. Muller A., Mungersdorf M., Reichmann H., Strehle G., and Hummel T. Olfactory function in Parkinsonian syndromes. J Clin Neurosci 9 (2002) 521-524
15. Siderowf A., Newberg A., Chou K.L., Lloyd M., Colcher A., Hurtig H.I., et al. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64 (2005) 1716-1720
16. Goldstein D.S., Eldadah B.A., Holmes C., Pechnik S., Moak J., Saleem A., et al. Neurocirculatory abnormalities in Parkinson disease with orthostatic hypotension. Independence from levodopa treatment. Hypertension 46 (2005) 1-7
17. Goldstein D.S., Holmes C., Bentho O., Sato T., Moak J., Sharabi Y., et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord 14 (2008) 600-607
18. Goldstein D.S., Holmes C., Sharabi Y., Brentzel S., and Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60 (2003) 1327-1332
19. Goldstein D.S., and Tack C. Non-invasive detection of sympathetic neurocirculatory failure. Clin Auton Res 10 (2000) 285-291
20. Gilman S., Low P., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C., et al. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 8 (1998) 359-362
21. Olichney J.M., Murphy C., Hofstetter C.R., Foster K., Hansen L.A., Thal L.J., et al. Anosmia is very common in the Lewy body variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry 76 (2005) 1342-1347
22. McShane R.H., Nagy Z., Esiri M.M., King E., Joachim C., Sullivan N., et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 70 (2001) 739-743
23. Ross G.W., Abbott R.D., Petrovitch H., Tanner C.M., Davis D.G., Nelson J., et al. Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21 (2006) 2062-2067
24. Braak H., de Vos R.A., Bohl J., and Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396 (2006) 67-72
25. Farooqui T. Octopamine-mediated neuronal plasticity in honeybees: implications for olfactory dysfunction in humans. Neuroscientist 13 (2007) 304-322
26. Ehringer H., and Hornykiewicz O. [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.]. Wien Klin Wochenschr 38 (1960) 1236-1239
27. Zarow C., Lyness S.A., Mortimer J.A., and Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60 (2003) 337-341
28. Barnett E.M., Cassell M.D., and Perlman S. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 57 (1993) 1007-1025
29. McLean J.H., Shipley M.T., Bernstein D.I., and Corbett D. Selective lesions of neural pathways following viral inoculation of the olfactory bulb. Exp Neurol 122 (1993) 209-222
30. Hamaue N., Ogata A., Terado M., Ohno K., Kikuchi S., Sasaki H., et al. Brain catecholamine alterations and pathological features with aging in Parkinson disease model rat induced by Japanese encephalitis virus. Neurochem Res 31 (2006) 1451-1455